Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-finding trial of NH102 hydrochloride tablets for major depressive disorder
CTR20243913Phase 2Completed
- Sponsor
- Jiangsu Nhwa Pharmaceutical
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NH-102 in major depressive disorder (MDD), sponsored by Jiangsu Nhwa Pharmaceutical. Started Nov 2024; status: completed.
02
Drugs
NH-102
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on CTR20243913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243913.